Optimal control in the treatment of retinitis pigmentosa

Area of Science:

• Ophthalmology and Computational Biology
• Degenerative Eye Diseases
• Photoreceptor Cell Biology

Background:

• Retinitis Pigmentosa (RP) is a group of inherited eye diseases causing progressive vision loss.
• Current therapies for RP offer limited long-term solutions, with no treatment halting photoreceptor degeneration.
• The RdCVF protein shows promise in slowing secondary cone cell death in RP.

Purpose of the Study:

• To incorporate RdCVF treatment regimens into an existing mathematical model of photoreceptor interactions in RP.
• To identify an optimal control strategy for RdCVF administration.
• To evaluate the therapeutic potential of RdCVF in a computational framework.

Main Methods:

• Development and analysis of a mathematical model simulating photoreceptor cell dynamics in RP.
• Integration of variable RdCVF treatment protocols into the model.
• Application of optimal control theory to determine RdCVF administration strategies.
• Numerical simulations to assess the impact of RdCVF on cone cell survival.

Main Results:

• The study identified an optimal control strategy for the administration of RdCVF.
• Numerical solutions demonstrated a rescue effect of RdCVF on cone cells, consistent with experimental observations.
• The model supports RdCVF as a potential therapeutic agent for slowing cone degeneration in RP.

Conclusions:

• Mathematical modeling provides a framework for understanding and optimizing RdCVF therapy for Retinitis Pigmentosa.
• An optimal administration strategy for RdCVF can enhance its therapeutic efficacy in preserving cone photoreceptors.
• RdCVF shows significant potential to mitigate vision loss associated with RP by protecting cone cells.